Review
Accepted on 29 Sep 2025
Treatment and Prognosis of Failure of First-Line Immunotherapy or Recurrent Autoimmune Encephalitis Patients with Ofatumumab—a fully human anti-CD20 mAb
in Multiple Sclerosis and Neuroimmunology
- 197 views
Review
Accepted on 29 Sep 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Accepted on 29 Sep 2025
in Neurological Biomarkers
Original Research
Accepted on 29 Sep 2025
in Plant Physiology
Original Research
Accepted on 29 Sep 2025
in Headache and Neurogenic Pain
Review
Accepted on 29 Sep 2025
in Stroke
Original Research
Accepted on 29 Sep 2025
in Plant Biophysics and Modeling
Original Research
Accepted on 29 Sep 2025
in Plant Cell Biology
Original Research
Accepted on 29 Sep 2025
in Learning and Memory
Original Research
Accepted on 29 Sep 2025
in Functional Plant Ecology
Editorial
Accepted on 29 Sep 2025
in Applied Neuroimaging
Original Research
Accepted on 29 Sep 2025
in Sustainable and Intelligent Phytoprotection
Study Protocol
Accepted on 29 Sep 2025
in Neurorehabilitation
Original Research
Published on 29 Sep 2025
in Access and Barriers to Reproductive Health Services
Original Research
Published on 29 Sep 2025
in Clinical and Diagnostic Microbiology and Immunology
Brief Research Report
Published on 29 Sep 2025
in Perinatal Psychiatry
Review
Published on 29 Sep 2025
in Plant Conservation